A Second Chance at RegistrationOrigent leverages advanced predictive analytics to rescue failed drug programs in ALS, Alzheimer’s, and other neurodegenerative diseases. Learn More About Drug Rescue Managing Drug Development Risk through Better ForesightPredicting patient-level dynamics allows researchers, drug developers, and investors better manage risks and reduce the costs of drug discovery. Our Mission Unparalleled ALS Predictive Modeling CapabilitiesOrigent's suite of predictive models accurately predict the progression of ALS and ALS symptoms. See our ALS Models Informed DiscoveryOrigent's clinical trial analysis tools help biotech firms conduct more cost efficient clinical trials and inform new experiments. Faster Insight for Biotech Fail FasterWe help pharmaceutical companies identify the most promising prospects in their drug development pipeline earlier, to eliminate failing projects and better prioritize scarce resources. Earlier Knowledge for Pharma Invest ConfidentlyOrigent has a unique method for helping biotech investors evaluate clinical trial data during due diligence. Venture Capital and Investors Managing Drug Development Risk through Better Foresight Learn More
